您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > JPE-1375
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
JPE-1375
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
JPE-1375图片
CAS NO:1254036-23-1
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
200mg电议
500mg电议

产品介绍
JPE-1375 是一种补体C5a受体 1 (C5aR1) 拮抗剂。JPE-1375 能有效抑制小鼠体内多形核白细胞动员 (EC50=6.9 μM) 和降低TNF水平 (EC50=4.5 μM)。JPE-1375 可用于自身免疫性和炎性疾病的研究。
生物活性

JPE-1375 is acomplement C5a receptor 1(C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 μM) and reducesTNFlevels (EC50=4.5 μM) in mice. JPE-1375 can be used in studies of autoimmune and inflammatory diseases[1].

IC50& Target

C5aR1[1].

体内研究
(In Vivo)

JPE-1375 (0.3, 1.0, 3.0 mg/kg; i.v.; single) inhibits PMN (polymorphonuclear leukocytes) mobilization and TNF with EC50values of 6.9 and 4.5 μM, respectively[1].
JPE-1375 (1 mg/kg; i.v.; single) demonstrates a rapid distribution in the plasma, followed by elimination in mice[1].
JPE-1375 (1 mg/kg; i.v.; single) shows a strong negative correlation between PMN mobilization and TNF production with plasma concentrations[1].

Animal Model:C57BL/6J wild-type (10 to 12-week-old; C5a pharmacodynamic model)[1].
Dosage:0.3, 1.0, 3.0 mg/kg
Administration:Intravenous injection; single.
Result:Significantly decreased C5a-mediated PMN mobilization at 1 and 3 mg/kg doses, while no effect was observed at a 0.3 mg/kg dose.
Showed a significant reduction in TNF plasma levels at 1 and 3 mg/kg dose with both compounds reducing C5a-mediated TNF by about 90%.
Animal Model:C57BL/6J wild-type mice(10 to 12-week-old)[1].
Dosage:1 mg/kg
Administration:Intravenous injection; single.
Result:1.19Pharmacokinetic Parameters of JPE-1375 in C57BL/6J wild-type mice[1].
IV (1 mg/kg)
T1/2(h)0.13
Cmax(μg/mL)7.18
AUC0-t(μg/mLoh)2.40
AUC0-inf, obs(μg/mLoh)2.41
AUC0-t/0-inf, obs(μg/mLoh)1.00
AUMC0-inf, obs(μg/mLoh2)0.13
MRT0-inf, obs(h)0.05
Vz, obs((μg)/(μg/mL))2.38
CL, obs ((μg)/(μg/mL)/h)12.47
Vss, obs((μg)/(μg/mL))0.66
分子量

955.08

性状

Solid

Formula

C49H63FN10O9

CAS 号

1254036-23-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
In Vitro: 

DMSO : 100 mg/mL(104.70 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM1.0470 mL5.2352 mL10.4703 mL
5 mM0.2094 mL1.0470 mL2.0941 mL
10 mM0.1047 mL0.5235 mL1.0470 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (protect from light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。